167 related articles for article (PubMed ID: 24443440)
1. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
Colucci G; Stutz M; Rochat S; Conte T; Pavicic M; Reusser M; Giabbani E; Huynh A; Thürlemann C; Keller P; Alberio L
Blood; 2014 Mar; 123(12):1905-16. PubMed ID: 24443440
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
Yang X; Disa J; Rao AK
Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
[TBL] [Abstract][Full Text] [Related]
4. Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
Daskalakis M; Colucci G; Keller P; Rochat S; Silzle T; Biasiutti FD; Barizzi G; Alberio L
Cytometry B Clin Cytom; 2014 Nov; 86(6):397-409. PubMed ID: 24677789
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
Parker RI; Gralnick HR
Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
[TBL] [Abstract][Full Text] [Related]
6. 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass.
Sloand EM; Alyono D; Klein HG; Chang P; Yu M; Lightfoot FG; Kessler C
Am J Hematol; 1994 Jul; 46(3):199-207. PubMed ID: 8192149
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Na+/H+ exchanger in desmopressin-induced platelet procoagulant response.
Tomasiak MM; Stelmach H; Bodzenta-Łukaszyk A; Tomasiak M
Acta Biochim Pol; 2004; 51(3):773-88. PubMed ID: 15448738
[TBL] [Abstract][Full Text] [Related]
8. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
9. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
10. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
Pfueller SL; Howard MA; White JG; Menon C; Berry EW
Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Oct; 121(10):1337-1344. PubMed ID: 33690868
[TBL] [Abstract][Full Text] [Related]
13. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
14. Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation.
Persyn M; Athanase N; Trossaërt M; Sigaud M; Ternisien C; Béné MC; Fouassier M
Hamostaseologie; 2022 Jun; 42(3):185-192. PubMed ID: 34139772
[TBL] [Abstract][Full Text] [Related]
15. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
[TBL] [Abstract][Full Text] [Related]
18. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa.
Lethagen S; Nilsson IM
Eur J Haematol; 1992 Jul; 49(1):7-13. PubMed ID: 1499698
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules.
Kanwar S; Woodman RC; Poon MC; Murohara T; Lefer AM; Davenpeck KL; Kubes P
Blood; 1995 Oct; 86(7):2760-6. PubMed ID: 7545469
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding.
Swieringa F; Lancé MD; Fuchs B; Feijge MA; Solecka BA; Verheijen LP; Hughes KR; van Oerle R; Deckmyn H; Kannicht C; Heemskerk JW; van der Meijden PE
J Thromb Haemost; 2015 Aug; 13(8):1503-13. PubMed ID: 25988848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
